Output from a PCSIG clinical trial – Impact of home blood sampling on recruitment and retention

Learn about the impact of collecting blood samples at home on trial recruitment and participant attitudes to the approach.

Patient centric blood sampling offers an alternative approach for the collection of biological samples in locations away from the clinical setting, such as at home. This webinar describes the outcomes of a cross organizational clinical trial that was designed to examine whether collecting patient centric blood samples at home, compared to the same approach in the clinic, had any impact on the recruitment and retention of trial participants. We also present data obtained from subject questionnaires on attitudes to these sampling approaches.

Of interest to:

  • Clinical researchers who wish to impact their trial recruitment and retention rates.
  • Healthcare providers seeking to integrate microsampling methods within patient pathways.
  • Developers of microsampling tools looking to understand patient perspectives.
  • Anyone impacted by blood sampling who is eager to explore more patient centric alternatives.

​​What you will learn

  • The impact of home patient centric blood sampling on clinical trial recruitment and retention rates, when compared to in-clinic sampling.
  • The attitude of participants to home sampling.

Speakers

Robyn Rourick

Senior Director, Outsourcing Portfolio Management, Genentech)

Robyn A Rourick is a Senior Director in Bioanalytical Sciences at Genentech, Inc., where she oversees bioanalytical outsourcing strategies in support of non-clinical and clinical PK, ADA and biomarkers. For 4 years prior, Robyn was a Senor Manager in Nonclinical Study Operations, where she oversaw outsourced non-clinical studies in support of pre- and post-IND programs. She served as a liaison between cross-functional groups for study-related requirements, as well as developed strategies to address operational efficiencies and process gaps in study execution. Prior to Genentech, she held the position of Director, Pharmaceutical Sciences, at Kalypsys, Inc., focused on analytical and pharmaceutical development activities in support of early phase clinical programs. Prior to Kalypsys, Robyn was Associate Director of DuPont Pharmaceuticals Research Labs and previous to that was Group Leader, Analytical Technologies at CombiChem, Inc., where she was involved in building an ensemble of analytical assays to assess performance of discovery compounds against development milestones. Prior to CombiChem, Robyn held positions of increasing responsibility over the course of 10 years at Bristol-Myers Squibb. During this time she championed the integration of LC/MS in different phases of drug development. Robyn received her BS in Chemistry from Fairfield University and her MS in Forensic Chemistry under the direction of Dr Henry Lee at the University of New Haven. Robyn is a Board Member of the Pharmaceutical & BioScience Society (PBSS) and chairs the San Diego Chapter.

Mike Walker

Statistics Consultant, Walker Bioscience

Michael Walker received his PhD from Stanford University, and taught statistics at Stanford for 25 years. He is a statistics consultant for pharmaceutical and biotechnology companies. His consulting work has led to FDA approvals for drugs, diagnostics, and devices, articles in the New England Journal of Medicine and in Lancet, and many patents. He consults for venture capital companies to evaluate investments in life sciences. He is author of the book, “How to Get P-values less than 0.05 in Biological Research: Practical examples of how to increase power, reduce sample size, and choose better statistics tests.”

Neil Spooner

Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group

Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organizations to develop technologies and introduce them to the market. Neil also assists organizations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.​​​​​​​

In association with